CD274 and neoplasm: Enhanced kynurenine levels within the tumor microenvironment stimulates AHR activation within T-cells resulting in elevated PD1 expression, which in combination with tumor cell intrinsic PDL1 expression introduce immune checkpoints leading to immune tolerance [123].